Device sales help push ResMed to revenue record
MELBOURNE: Sleep disorder and breathing devices company ResMed has surpassed $US1 billion ($1.4 billion) in
MELBOURNE: Sleep disorder and breathing devices company ResMed has surpassed $US1 billion ($1.4 billion) in
FEATURED
Special research team creates ‘predictive medicine’ AI tool
Gen Z fear they will be poorest generation
New development earmarked for hospitality and multigenerational living
Public notification opens for 25-unit project on former landfill
Nine-story homeless tower rejected by council in shock vote
Multigenerational affordable housing planned for regeneration site
INNOVATION
